Related Experiment Video
Updated: Aug 14, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
The early history of myasthenia gravis
1Green College, University of Oxford, UK.
Abstract:
Myasthenia gravis was first recognised as a distinct clinical entity by Thomas Willis, a 17th century Oxford physician, whose 1672 account in Latin was largely unnoticed until 1903. The first modern description was made in 1877 by Samuel Wilks, a London physician. Towards the close of the 19th century, primary muscle diseases and diseases due to denervation of muscle were studied by English, French, and German physicians. The first full descriptions of myasthenia gravis were by Wilhelm Erb, of Heidelberg, and Samuel Goldflam of Warsaw. The account by Willis, and the 19th century literature of myasthenia gravis are reviewed, revealing the dominance of German physicians and neuropathologists in the early understanding of the disease. The development in pathology, aetiology, and therapy in the first half of the 20th century are described.
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
